Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO

ABSTRACT: Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO

PROVIDER: PRJEB22183 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2097200.fastq.gz	Fastqsanger.gz
	ERR2097201.fastq.gz	Fastqsanger.gz
	ERR2097196.fastq.gz	Fastqsanger.gz
	ERR2097197.fastq.gz	Fastqsanger.gz
	ERR2097198.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO

Project description:To determine changes of gene expression in human CD4+ T cells (Jurkat) infected with HIV-1 and treated with digoxin. Cells were infected (MOI 0.01) with a single cycle HIV-1 delta env expressing GFP and pseudotyoed with VSV-G in the presence of 400nM digoxin or DMSO. Cells were harvested 36 hours post-infection and processed for RNAseq

2017-08-19 | E-MTAB-5982 | biostudies-arrayexpress

Transcriptional profiling of HIV dual reporter infected Jurkat T cells using CAGE.

Project description:This study examine the transcriptional profiling of HIV dual reporter non-infected, latetnly infected and productively infected Jurkat T cells.

2021-01-21 | GSE149492 | GEO

RNA splicing patterns contribute to burst size variation among HIV-1 infected Jurkat cell clones

Project description:Jurkat T cells were infected with barcoded HIV-1, and the resulting polyclonal pool was analyzed to identify factors contributing to burst size variation among HIV-1 infected cell clones.

2025-02-17 | GSE289347 | GEO

Transcriptional Profiling of Untreated, HIV-1 Vector-Infected and TNFalpha-treated Jurkat T cells

Project description:Jurkat T cells (in triplicate per treatment group) were left untreated in culture, infected with VSV-G-pseudotyped HIV-based vector (which transduces Tat and eGFP) or treated with TNFalpha. Keywords: parallel sample

2005-04-07 | GSE2504 | GEO

Transcription profiling of untreated, HIV-1 vector-infected and TNFalpha-treated human Jurkat T cells

2007-08-25 | E-GEOD-2504 | biostudies-arrayexpress

Single Cell Multiome of isogenic HIV-1-infected Jurkat T cells

Project description:Single Cell Multiome of isogenic HIV-1-infected Jurkat T cells

| PRJNA956825 | ENA

Transcriptional profiling of HIV dual reporter infected Jurkat T cells using CAGE.

Project description:Transcriptional profiling of HIV dual reporter infected Jurkat T cells using CAGE.

| PRJNA628879 | ENA

HIV-1 SortSeq identifies HIV-1-infected cells from HIV-1-infected individuals

Project description:Using HIV-1 SortSeq, we identified HIV-1-infected cells containing inducible HIV-1 for RNAseq from resting CD4+ T cells treated with PMA/ionomycin for 16 hours from HIV-1-infected, antiretroviral therapy treated, virally suppressed individuals. Using custom bioinformatic pipeline, we identified HIV-1 genomic RNA, host RNA and HIV-1-host chimeric RNA junctions.

2020-05-15 | GSE126230 | GEO

Single Cell Multiome of isogenic HIV-1-infected Jurkat T cells

Project description:HIV-1 integration introduces ectopic transcription factor binding sites into host chromatin. We postulate that the integrated provirus serves as an ectopic enhancer that recruits additional transcriptional factors to the integration locus, increases chromatin accessibility, changes 3D chromatin interactions, and enhances both retroviral and host gene expression. We used 4 well-characterized HIV-1-infected cell line clones having unique integration sites and low to high levels of HIV-1 expression. Using single-cell DOGMA-seq, which captured the heterogeneity of HIV-1 expression and host chromatin accessibility, we found that HIV-1 transcription correlated with HIV-1 accessibility and host chromatin accessibility. HIV-1 integration increased local host chromatin accessibility within ~5–30 kb distance. CRISPRa and CRISPRi-mediated HIV-1 promoter activation and inhibition confirmed integration site-dependent HIV-1-driven changes of host chromatin accessibility. HIV-1 did not drive chromatin confirmation changes at the genomic level (by Hi-C) or the enhancer connectome (by H3K27Ac HiChIP). Using 4C-seq to interrogate HIV-1-chromatin interactions, we found that HIV-1 interacted with host chromatin ~100–300 kb from the integration site. By identifying chromatin regions having both increased transcription factor activity (by ATAC-seq) and HIV-1-chromtain interaction (by 4C-seq), we identified enrichment of ETS, RUNT, STAT, and ZNF transcription factor binding that may mediate HIV-1-host chromatin interactions. Our study found that HIV-1 promoter activity increased host chromatin accessibility, increased HIV-1-host chromatin interactions in an integration site dependent manner, within the existing chromatin boundaries without impacting broader host chromatin structure.

2023-05-01 | GSE229928 | GEO

E-MTAB-5982

Project description:Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO

2025-01-23 | E-MTAB-5982 | ExpressionAtlas